A multi-targeting natural compound with growth inhibitory and anti-angiogenic properties re-sensitizes chemotherapy resistant cancer

Targeted therapies have become the focus of much of the cancer therapy research conducted in the United States. While these therapies have made vast improvements in the treatment of cancer, their results have been somewhat disappointing due to acquired resistances, high cost, and limited populations...

Descripción completa

Detalles Bibliográficos
Autores principales: Taylor, Wesley F., Moghadam, Sara E., Moridi Farimani, Mahdi, N. Ebrahimi, Samad, Tabefam, Marzieh, Jabbarzadeh, Ehsan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559640/
https://www.ncbi.nlm.nih.gov/pubmed/31185048
http://dx.doi.org/10.1371/journal.pone.0218125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6559640/
https://www.ncbi.nlm.nih.gov/pubmed/31185048
http://dx.doi.org/10.1371/journal.pone.0218125

Ejemplares similares